Who
Kelly T. McKee Jr.
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, GeoVax Labs.
In numbers
- Trades disclosed
- 11
- Buys
- 6
- Sells
- 0
- Bought
- $24K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 4 May 2022
- Last trade
- 17 Jun 2026
- Last filed
- 22 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Jun 2026filed 22 Jun 2026 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —17,600 at $0.00 | filing |
| 17 Jun 2026filed 22 Jun 2026 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —17,600 at $0.00 | filing |
| 7 Aug 2025filed 8 Aug 2025 | GOVX GeoVax LabsBiotechnology | SEC FORM 4 Bought | $7421,107 at $0.67 | filing |
| 5 Jun 2025filed 6 Jun 2025 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —70,000 at $0.00 | filing |
| 12 Aug 2024filed 14 Aug 2024 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,700 at $0.00 | filing |
| 22 Dec 2023filed 26 Dec 2023 | GOVX GeoVax LabsBiotechnology | SEC FORM 4 Bought | $2,5006,944 at $0.36 | filing |
| 25 Sep 2023filed 27 Sep 2023 | GOVX GeoVax LabsBiotechnology | SEC FORM 4 Bought | $5,0209,653 at $0.52 | filing |
| 1 Aug 2023filed 14 Aug 2023 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 27 Jun 2022filed 28 Jun 2022 | GOVX GeoVax LabsBiotechnology | SEC FORM 4 Bought | $5,0004,464 at $1.12 | filing |
| 5 May 2022filed 6 May 2022 | GOVX GeoVax LabsBiotechnology | SEC FORM 4 Bought | $7,0009,722 at $0.72 | filing |
| 4 May 2022filed 5 May 2022 | GOVX GeoVax LabsBiotechnology | SEC FORM 4 Bought | $3,5494,999 at $0.71 | filing |
News
Lisata Therapeutics (NASDAQ:LSTA) & GeoVax Labs (NASDAQ:GOVX) Head to Head ContrastGOVX · dailypolitical.com · 8 Oct 2026
0 headlines in the last 90 days name Kelly T. McKee Jr.; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.